NUMANS(02530) has launched a new DHA algae oil product.

date
12:19 10/06/2026
avatar
GMT Eight
Neumann Health (02530) announced that the group has launched a new DHA algae oil product as part of its expanded product portfolio.
NUMANS (02530) announces that the Group has launched a new DHA algae oil product as part of its product portfolio expansion. (1) Premium Series - Children's DHA Algae Oil Product The Group has introduced a new DHA algae oil product called "NUMANS DHA Algae Oil (with docosahexaenoic acid)", which is an extension of its existing DHA algae oil products and is formulated using DHA raw materials sourced from DSM (an internationally recognized nutritional ingredient supplier for the Group's existing products). This product is targeted towards children aged 6 to 16, extending the Group's existing high-end brand positioning into the school-age children market. (2) Mid-range Market Series - DHA Algae Oil Products using European imported raw materials The Group has launched a new series of DHA algae oil products called "European Edition NUMANS DHA Algae Oil", produced using raw materials imported from Europe. This series is positioned at a lower retail price targeting the mid-range market to address the changing consumption patterns in China and the increasing consumer sentiment towards pricing. This series of products covers pregnant women, infants, toddlers, and school-age children. All these new products are now available for purchase on the Group's major online e-commerce platforms, including general trade (imports) and cross-border e-commerce models, as well as the Group's offline distribution channels. The Board believes that the introduction of these new products expands the Group's product portfolio and customer base, extending its coverage to a wider range of age groups and price ranges. The commercial performance of the new products is in the early stages, and it will be influenced by factors such as market acceptance, consumer demand, and competition. Therefore, there is no guarantee that the new products will achieve the expected sales or make a significant contribution to the Group's financial performance.